Pharma Stock Roundup: AZN's New Acquisition, FDA Updates for NVO & LLY and More
https://www.zacks.com/stock/news/2241296/pharma-stock-roundup-azn-s-new-acquisition-fda-updates-for-nvo-lly-and-more?cid=CS-ZC-FT-analyst_blog|stock_roundup-2241296
Mar 15, 2024 - AstraZeneca (AZN) is set to buy a private rare disease drugmaker. FDA delays decision on Lilly's (LLY) donanemab and approves Novo Nordisk's (NVO) Wegovy for reducing cardiovascular risks.
0
3 Unstoppable Stocks You Can Buy Now Without Any Hesitation
https://www.fool.com/investing/2024/03/17/3-unstoppable-stocks-you-can-buy-now-without-any/?source=iedfolrf0000001
Mar 17, 2024 - There's no need for delays in buying these great stocks.
0
Novo Nordisk's New Weight Loss Drug Could Be Better Than Ozempic and Wegovy
https://www.fool.com/investing/2024/03/21/novo-nordisks-new-weight-loss-drug-could-be-better/?source=iedfolrf0000001
Mar 21, 2024 - Has Novo Nordisk's already red-hot stock become an even better buy?
0
Novo Nordisk (NVO) Gets Positive CHMP Opinion for Insulin Icodec
https://www.zacks.com/stock/news/2245039/novo-nordisk-nvo-gets-positive-chmp-opinion-for-insulin-icodec?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2245039
Mar 22, 2024 - Novo Nordisk (NVO) receives a positive opinion from the CHMP for once-weekly basal insulin icodec for the treatment of diabetes in adults.
0
Pharma Stock Roundup: ABBV & NVO's New M&As, FDA Nod to JNJ & MRK PAH Drugs
https://www.zacks.com/stock/news/2247400/pharma-stock-roundup-abbv-nvo-s-new-m-as-fda-nod-to-jnj-mrk-pah-drugs?cid=CS-ZC-FT-analyst_blog|stock_roundup-2247400
Mar 28, 2024 - While AbbVie (ABBV) is set to buy Landos Biopharma, Novo Nordisk (NVO) is set to acquire Cardior Pharmaceuticals. FDA approves J&J's (JNJ) and Merck's (MRK) PAH drugs.
0
Why Novo Nordisk (NVO) is a Top Stock for the Long-Term
https://www.zacks.com/stock/news/2247877/why-novo-nordisk-nvo-is-a-top-stock-for-the-long-term?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_focus_list-2247877
Mar 29, 2024 - Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Focus List.
0
Is Novo Nordisk the Best Healthcare Stock for You?
https://www.fool.com/investing/2024/03/31/is-novo-nordisk-the-best-healthcare-stock-for-you/?source=iedfolrf0000001
Mar 31, 2024 - Novo Nordisk has been a hot buy in recent years, but in the long run, the stock can still go a whole lot higher.
0
Wall Street Analysts Think Novo Nordisk (NVO) Is a Good Investment: Is It?
https://www.zacks.com/stock/news/2249062/wall-street-analysts-think-novo-nordisk-nvo-is-a-good-investment-is-it?cid=CS-ZC-FT-fundamental_analysis|average_broker_rating-2249062
Apr 02, 2024 - The average brokerage recommendation (ABR) for Novo Nordisk (NVO) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
0
Healthcare ETFs for the Weight-Loss Drug Boom & Beyond
https://www.zacks.com/stock/news/2252191/healthcare-etfs-for-the-weight-loss-drug-boom-beyond?cid=CS-ZC-FT-etf_spotlight-2252191
Apr 08, 2024 - We discuss attractive investment opportunities within the healthcare industry.
0
Novo Nordisk and Ginkgo Bioworks Are Teaming Up. Here's Why That's Bullish for Both Stocks.
https://www.fool.com/investing/2024/04/15/novo-nordisk-and-ginkgo-bioworks-are-teaming-up/?source=iedfolrf0000001
Apr 15, 2024 - The collaboration could help solve challenges for both businesses.
0